News

Financial Performance. Cigna has demonstrated resilience in its financial performance, with analysts projecting solid earnings growth. For the fiscal year 2025, earnings per share (EPS) estimates ...
This analysis is based on information available up to May 27, 2025, and reflects the most recent analyst reports and company performance data provided. For comprehensive insights into Cigna’s ...
With an expected EPS of $28.94 for FY2025 and a current P/E ratio of 26.3x, InvestingPro analysis reveals 12 additional key insights about Cigna’s growth prospects and market position.
Cigna Group's performance and all-time high raise questions about selling its stock, but I still prefer to hold despite high valuation. Read more on CI stock here.
Cigna (NYSE:CI) has had a great run on the share market with its stock up by a significant 14% over the last three months. Given the company's impressive performance, we decided to study its ...
Despite the decline in income for Cigna, total and adjusted revenues have surged. Click here to read my technical analysis of CI stock and why it is a Buy.
Cigna (CI) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...
This was the stock's third consecutive day of losses.
In the latest market close, Cigna (CI) reached $292.07, with a +0.54% movement compared to the previous day. The stock outpaced the S&P 500's daily gain of 0.45%.
Cigna Corporation (NYSE:CI), a global health service organization with a market capitalization of $87 billion, has been navigating a complex landscape of market shifts, regulatory changes, and ...
Cigna Corporation (NYSE:CI), a global health service organization with a market capitalization of $87 billion, has been navigating a complex landscape of market shifts, regulatory changes, and ...